Synaptic Mitochondrial Pathology in Alzheimer's Disease

Abstract

Significance: Synaptic degeneration, an early pathological feature in Alzheimer's disease (AD), is closely correlated to impaired cognitive function and memory loss. Recent studies suggest that involvement of amyloid-beta peptide (Ab) in synaptic mitochondrial alteration underlies these synaptic lesions. Thus, to understand the Abassociated synaptic mitochondrial perturbations would fortify our understanding of synaptic stress in the pathogenesis of AD. Recent Advances: Increasing evidence suggests that synaptic mitochondrial dysfunction is strongly associated with synaptic failure in many neurodegenerative diseases including AD. Based on recent findings in human AD subjects, AD animal models, and AD cellular models, synaptic mitochondria undergo multiple malfunctions including Ab accumulation, increased oxidative stress, decreased respiration, and compromised calcium handling capacity, all of which occur earlier than changes seen in nonsynaptic mitochondria before predominant AD pathology. Of note, the impact of Ab on mitochondrial motility and dynamics exacerbates synaptic mitochondrial alterations. Critical Issues: Synaptic mitochondria demonstrate early deficits in AD; in combination with the role that synaptic mitochondria play in sustaining synaptic functions, deficits in synaptic mitochondria may be a key factor involved in an early synaptic pathology in AD. Future Directions: The importance of synaptic mitochondria in supporting synapses and the high vulnerability of synaptic mitochondria to Ab make them a promising target of new therapeutic strategy for AD.

Compromised MAPK signaling in human diseases: an update

“…FUS is a DNA-and RNA-binding protein that contributes to DNA damage repair, mRNA splicing, and microRNA (miRNA) biogenesis. l An expansion of GGGGCC repeats in the noncoding region of the C9orf 72 gene results in the production of neurotoxic dipeptide repeat proteins such as poly(Gly-Ala), poly(Gly-Pro), poly(Gly-Arg), poly(Pro-Arg), and poly(Pro-Ala) in motor neurons ◂ signaling (Du et al 2012). Cyclophilin D (CypD), a subunit of the mitochondrial permeability transition pore, has been suggested to function as an Aβ receptor in mitochondria (Baines et al 2005;Du et al 2008).…”

Design, synthesis and in vitro evaluation of benzothiazole-based ureas as potential ABAD/17β-HSD10 modulators for Alzheimer’s disease treatment

“…2 Even though a precise mechanism of Aβ-induced toxicity has not been fully understood, several studies have reported synaptic and mitochondrial Aβ accumulation and dysfunction in early stages of AD development. [2][3][4] Furthermore, it has been described that Aβ interacts with various mitochondrial proteins, resulting in enhanced oxidative stress, energy misbalance and overall cell toxicity.…”

Could Alzheimer’s Disease Originate in the Periphery and If So How So?

“…The association between impaired mitochondrial performance and the development of synaptic dysfunction is not unexpected as these organelles are involved in every stage of neurotransmission including the synthesis and storage of neurotransmitters, the trafficking and recycling of synaptic vesicles (SVs), presynaptic neurotransmitter release, neurotransmitter synthesis, calcium ion homeostasis as well as supplying ATP and regulating levels of ROS [240][241][242].…”